Resmed (RMD) Net Shares Issued and Repurchased (2011 - 2021)
Resmed's (RMD) quarterly Net Shares Issued and Repurchased came in at $56000.0 in Q2 2021, down 65.43% on a YoY basis from $162000.0 in Q2 2020, and down 65.43% quarter-over-quarter from $162000.0 in Q2 2020.
Powered by 
Analysis
Resmed (RMD) Net Shares Issued and Repurchased (2011 - 2021) Analysis & Trends
Resmed (RMD) has reported Net Shares Issued and Repurchased for 11 consecutive years, with $56000.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Net Shares Issued and Repurchased fell 65.43% year-over-year to $56000.0; the trailing twelve-month figure through Jun 2021 stood at $56000.0 (down 65.43% YoY), and the FY2021 full-year result was $56000.0, down 65.43% from the prior year.
- Net Shares Issued and Repurchased declined to $56000.0 in Q2 2021 per RMD's latest filing, from $162000.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $306842.0 in Q2 2019 and bottomed at $183.0 in Q3 2018.
- Historically, Net Shares Issued and Repurchased has averaged $83036.5 across 5 years, with a median of $56392.0 in 2017.
- The sharpest annual moves came in 2018 and 2019: Net Shares Issued and Repurchased tumbled 95.66% in 2018, then soared 3375.96% in 2019.
- Over 5 years, Net Shares Issued and Repurchased stood at $4212.0 in 2017, then sank by 95.66% to $183.0 in 2018, then jumped by 3375.96% to $6361.0 in 2019, then surged by 2446.77% to $162000.0 in 2020, then plunged by 65.43% to $56000.0 in 2021.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $56000.0, $162000.0, and $6361.0 for Q2 2021, Q2 2020, and Q3 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | - |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | - |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 56,000.00 |
| Jun 30, 2020 | 162,000.00 |
| Sep 30, 2019 | 6,361.00 |
| Jun 30, 2019 | 306,842.00 |
| Sep 30, 2018 | 183.00 |
| Jun 30, 2018 | 71,910.00 |
| Sep 30, 2017 | 4,212.00 |
| Jun 30, 2017 | 56,784.00 |
| Sep 30, 2016 | 17,010.00 |
| Jun 30, 2016 | 31,398.00 |
| Sep 30, 2015 | 12,546.00 |
| Jun 30, 2015 | 23,812.00 |
| Sep 30, 2014 | 13,823.00 |
| Jun 30, 2014 | 109,280.00 |
| Sep 30, 2013 | 10,250.00 |
| Jun 30, 2013 | 59,550.00 |
| Sep 30, 2012 | 34,700.00 |
| Jun 30, 2012 | 386,800.00 |
| Sep 30, 2011 | 185,250.00 |
| Jun 30, 2011 | 915,498.00 |